Targeting amino acid metabolism in cancer growth and anti-tumor immune response
Identifieur interne : 001776 ( Main/Exploration ); précédent : 001775; suivant : 001777Targeting amino acid metabolism in cancer growth and anti-tumor immune response
Auteurs : Elitsa AnanievaSource :
- World Journal of Biological Chemistry [ 1949-8454 ] ; 2015.
Abstract
Recent advances in amino acid metabolism have revealed that targeting amino acid metabolic enzymes in cancer therapy is a promising strategy for the development of novel therapeutic agents. There are currently several drugs in clinical trials that specifically target amino acid metabolic pathways in tumor cells. In the context of the tumor microenvironment, however, tumor cells form metabolic relationships with immune cells, and they often compete for common nutrients. Many tumors evolved to escape immune surveillance by taking advantage of their metabolic flexibility and redirecting nutrients for their own advantage. This review outlines the most recent advances in targeting amino acid metabolic pathways in cancer therapy while giving consideration to the impact these pathways may have on the anti-tumor immune response.
Url:
DOI: 10.4331/wjbc.v6.i4.281
PubMed: 26629311
PubMed Central: 4657121
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000496
- to stream Pmc, to step Curation: 000496
- to stream Pmc, to step Checkpoint: 000E33
- to stream Ncbi, to step Merge: 007B87
- to stream Ncbi, to step Curation: 007B87
- to stream Ncbi, to step Checkpoint: 007B87
- to stream Main, to step Merge: 001778
- to stream Main, to step Curation: 001776
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Targeting amino acid metabolism in cancer growth and anti-tumor immune response</title><author><name sortKey="Ananieva, Elitsa" sort="Ananieva, Elitsa" uniqKey="Ananieva E" first="Elitsa" last="Ananieva">Elitsa Ananieva</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">26629311</idno><idno type="pmc">4657121</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657121</idno><idno type="RBID">PMC:4657121</idno><idno type="doi">10.4331/wjbc.v6.i4.281</idno><date when="2015">2015</date><idno type="wicri:Area/Pmc/Corpus">000496</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000496</idno><idno type="wicri:Area/Pmc/Curation">000496</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000496</idno><idno type="wicri:Area/Pmc/Checkpoint">000E33</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000E33</idno><idno type="wicri:Area/Ncbi/Merge">007B87</idno><idno type="wicri:Area/Ncbi/Curation">007B87</idno><idno type="wicri:Area/Ncbi/Checkpoint">007B87</idno><idno type="wicri:doubleKey">1949-8454:2015:Ananieva E:targeting:amino:acid</idno><idno type="wicri:Area/Main/Merge">001778</idno><idno type="wicri:Area/Main/Curation">001776</idno><idno type="wicri:Area/Main/Exploration">001776</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Targeting amino acid metabolism in cancer growth and anti-tumor immune response</title><author><name sortKey="Ananieva, Elitsa" sort="Ananieva, Elitsa" uniqKey="Ananieva E" first="Elitsa" last="Ananieva">Elitsa Ananieva</name></author></analytic><series><title level="j">World Journal of Biological Chemistry</title><idno type="ISSN">1949-8454</idno><idno type="eISSN">1949-8454</idno><imprint><date when="2015">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Recent advances in amino acid metabolism have revealed that targeting amino acid metabolic enzymes in cancer therapy is a promising strategy for the development of novel therapeutic agents. There are currently several drugs in clinical trials that specifically target amino acid metabolic pathways in tumor cells. In the context of the tumor microenvironment, however, tumor cells form metabolic relationships with immune cells, and they often compete for common nutrients. Many tumors evolved to escape immune surveillance by taking advantage of their metabolic flexibility and redirecting nutrients for their own advantage. This review outlines the most recent advances in targeting amino acid metabolic pathways in cancer therapy while giving consideration to the impact these pathways may have on the anti-tumor immune response.</p></div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Ananieva, Elitsa" sort="Ananieva, Elitsa" uniqKey="Ananieva E" first="Elitsa" last="Ananieva">Elitsa Ananieva</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001776 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001776 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4657121
|texte= Targeting amino acid metabolism in cancer growth and anti-tumor immune response
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26629311" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |